purchases of short-term marketable securities , net of sales of short-term marketable securities during the quarter .additionally , we incurred $ 3.8 million related to cash expenditures for property and equipment primarily on computer software projects and manufacturing equipment related to our expansion in ireland .our financing activities during the year ended march 31 , 2009 provided cash of $ 46.2 million as compared to $ 2.1 million during the same period in the prior year .cash provided by financing activities for the year ended march 31 , 2009 was primarily comprised of $ 42.0 million in net proceeds related to our august 2008 public offering and $ 5.0 million attributable to the exercise of stock options and proceeds from our employee stock purchase plan .capital expenditures for fiscal 2010 are estimated to be $ 2.5 to $ 3.0 million , which relate primarily to our planned manufacturing capacity increases for impella in germany , our expansion in ireland , and software development projects .our liquidity is influenced by our ability to sell our products in a competitive industry and our customers 2019 ability to pay for our products .factors that may affect liquidity include our ability to penetrate the market for our products , maintain or reduce the length of the selling cycle , and collect cash from clients after our products are sold .exclusive of activities involving any future acquisitions of products or companies that complement or augment our existing line of products , we believe that current available funds and cash generated from operations will provide sufficient liquidity to meet operating requirements for the foreseeable future .we believe that our existing cash balances and cash flow from operations will be sufficient to meet our projected capital expenditures , working capital , and other cash requirements at least through the next 12 months .we continue to review our long-term cash needs on a regular basis .currently , we have no debt outstanding .contractual obligations and commercial commitments the following table summarizes our contractual obligations at march 31 , 2009 and the effects such obligations are expected to have on our liquidity and cash flows in future periods .payments due by fiscal year ( in $ 000 2019s ) contractual obligations total than 1 than 5 .
[['contractual obligations', 'payments due by fiscal year ( in $ 000 2019s ) total', 'payments due by fiscal year ( in $ 000 2019s ) less than 1 year', 'payments due by fiscal year ( in $ 000 2019s ) 1-3 years', 'payments due by fiscal year ( in $ 000 2019s ) 3-5 years', 'payments due by fiscal year ( in $ 000 2019s ) more than 5 years'], ['operating lease commitments', '$ 10690', '$ 2313', '$ 4267', '$ 2592', '$ 1518'], ['contractual obligations ( 1 )', '9457', '4619', '4838', '2014', '2014'], ['total obligations', '$ 20147', '$ 6932', '$ 9105', '$ 2592', '$ 1518']]
( 1 ) contractual obligations represent future cash commitments and expected liabilities under agreements with third parties for clinical trials .we have no long-term debt , capital leases or other material commitments for open purchase orders and clinical trial agreements at march 31 , 2009 other than those shown in the table above .in may 2005 , we acquired all the shares of outstanding capital stock of impella cardiosystems ag , a company headquartered in aachen , germany .the aggregate purchase price excluding contingent payments , was approximately $ 45.1 million , which consisted of $ 42.2 million of our common stock , $ 1.6 million of cash paid to certain former shareholders of impella and $ 1.3 million of transaction costs , consisting primarily of fees paid for financial advisory and legal services .at the time of the transaction , we agreed to make additional contingent payments to impella 2019s former shareholders based on additional milestone payments related to product sales and fda approvals in the amount of up to $ 16.8 million .in january 2007 upon the sale of 1000 impella units , we paid $ 5.6 million in the form of common stock .in june 2008 we received 510 ( k ) clearance of our impella 2.5 , and we paid $ 5.6 million in the form of common stock .in april 2009 , we received 501 ( k ) clearance of our impella 5.0 , triggering an obligation to make the final$ 5.6 million milestone payment .on may 15 , 2009 , we paid $ 1.75 million of this final milestone in cash and elected to pay the remaining amount through the issuance of approximately 664612 shares of our common stock .this contingent payment will result in an increase to the carrying value of goodwill .in june 2008 , we amended the lease for our facility in danvers , massachusetts .the amendment extended the lease from february 28 , 2010 to february 28 , 2016 .the lease continues to be accounted for as an operating lease .the amendment changed the rent payments under the lease from $ 64350 per month to the following schedule : 2022 the base rent for july 2008 through october 2008 was $ 0 per month ; 2022 the base rent for november 2008 through june 2010 is $ 40000 per month ; 2022 the base rent for july 2010 through february 2014 will be $ 64350 per month ; and 2022 the base rent for march 2014 through february 2016 will be $ 66000 per month. .

Question: what are the total contractual commitments , in millions?
Answer: 40294